Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The infection of a fly larva (maggot) in human tissue, which most commonly occurs in tropical climates. Affected tissues most commonly include skin, especially if open wounds are present, nasal passages, ears, and eyes.
Biomarker and diagnostic research for myiasis has been reported in the published literature.
No clinical trials have been registered for myiasis.
239 publications have been identified in PubMed for myiasis. Kisho has analyzed 70 by research type. Research spans Case Report / Case Series (51%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 36 | 51% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:28 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
16 |
23% |
Laboratory research | 7 | 10% |
Disease patterns and progression | 7 | 10% |
Testing and diagnosis research | 2 | 3% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Gupta AK (2026). [PMID: 42133099](https://pubmed.ncbi.nlm.nih.gov/42133099/). *Support Care Cancer*. [Review / Meta-Analysis]
Silva LM (2026). [PMID: 41572463](https://pubmed.ncbi.nlm.nih.gov/41572463/). *Pediatr Infect Dis J*. [Case Report / Case Series]
Shimizu S (2026). [PMID: 40803864](https://pubmed.ncbi.nlm.nih.gov/40803864/). *Intern Med*. [Basic Science / Preclinical]
Rodriguez-Vivas RI (2026). [PMID: 41754429](https://pubmed.ncbi.nlm.nih.gov/41754429/). *Pathogens*. [Review / Meta-Analysis]
Gamboa S (2026). [PMID: 41505931](https://pubmed.ncbi.nlm.nih.gov/41505931/). *Am J Emerg Med*. [Case Report / Case Series]
Togni Filho PHA (2026). [PMID: 41637349](https://pubmed.ncbi.nlm.nih.gov/41637349/). *Rev Inst Med Trop Sao Paulo*. [Review / Meta-Analysis]
Warghane R (2026). [PMID: 42180627](https://pubmed.ncbi.nlm.nih.gov/42180627/). *Pan Afr Med J*. [Case Report / Case Series]
Xiao Q (2026). [PMID: 42222065](https://pubmed.ncbi.nlm.nih.gov/42222065/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Snyder A (2026). [PMID: 42038424](https://pubmed.ncbi.nlm.nih.gov/42038424/). *Case Rep Ophthalmol Med*. [Epidemiology / Natural History]
Galván-Casas C (2026). [PMID: 40567146](https://pubmed.ncbi.nlm.nih.gov/40567146/). *Clin Exp Dermatol*. [Review / Meta-Analysis]
AI-curated news mentioning myiasis
Updated Aug 29, 2026
FDA has issued Emergency Use Authorizations for three animal drugs aimed at preventing and treating infestations caused by New World screwworm larvae. This decision impacts livestock including dairy cattle, horses, swine, sheep, and deer.
FDA grants Emergency Use Authorization for Bimectin (ivermectin) to prevent New World screwworm infestations in cattle. The drug is effective when administered within 24 hours of birth, during castration, or upon wound appearance.
FDA grants Emergency Use Authorization for Simparica TRIO, a chewable tablet combining sarolaner, moxidectin, and pyrantel, to treat New World screwworm infestations in dogs and puppies. This approval addresses a critical need for effective treatment against myiasis in affected animals.
FDA grants Emergency Use Authorization for CLiK Extra, a topical spray aimed at preventing New World screwworm infestations in livestock including sheep, cattle, goats, and swine. This approval addresses a critical need in veterinary medicine to combat myiasis.
A case report details advanced periorbital squamous cell carcinoma complicated by extensive facial myiasis in a homeless patient. This unique presentation highlights the intersection of severe skin cancer and parasitic infection, emphasizing the need for awareness in vulnerable populations.